Orbimed Advisors - JUNO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$83,886,000
-8.4%
1,835,188
-10.1%
1.06%
+21.3%
Q3 2017$91,587,000
+234.8%
2,041,608
+123.1%
0.88%
+204.9%
Q2 2017$27,356,000915,2080.29%
Other shareholders
JUNO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Biomark Capital Management Co. LLC 1,864,174$83,627,00094.97%
Crestline Management, LP 9,348,799$419,387,00058.30%
Omega Fund Management, LLC 1,074,612$48,207,00027.27%
PECONIC PARTNERS LLC 570,000$25,570,0004.12%
SIB LLC 100,000$4,486,0003.22%
Cormorant Asset Management, LP 375,000$16,823,0002.97%
BB BIOTECH AG 2,055,000$92,187,0002.55%
Clarius Group, LLC 117,896$5,289,0002.23%
Monashee Investment Management LLC 122,000$5,473,0002.07%
Iguana Healthcare Management, LLC 150,000$6,730,0001.86%
View complete list of JUNO THERAPEUTICS INC shareholders